Insulin resistance (IR), a central feature of metabolic syndrome [7], is characterized by a dysregulated biological response to insulin, leading to increased glycemia and an increased risk of Type 2 diabetes (T2D), hypertension (HTN) and dyslipidaemia [8]. This evidence concerns the gene INS and hypertensive disorder.